Aluminum zirconium tetrachlorohydrex gly
CAS 134910-86-4
Aluminum zirconium tetrachlorohydrex gly (CAS 134910-86-4) is a pharmaceutical compound with 0 bioactivity targets and 12 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Aluminum zirconium tetrachlorohydrex gly is linked to DTXSID601021350 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Aluminum zirconium tetrachlorohydrex gly used for in pharmaceutical contexts?
Aluminum zirconium tetrachlorohydrex gly (CAS 134910-86-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Aluminum zirconium tetrachlorohydrex gly?
Aluminum zirconium tetrachlorohydrex gly has 12 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Application site erythema, Application site exfoliation, Application site pain, Application site swelling, Dermatitis contact. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Aluminum zirconium tetrachlorohydrex gly also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Aluminum Zirconium Tetrachlorohydrex Gly with EU status "restricted".
What clinical phase is Aluminum zirconium tetrachlorohydrex gly in?
No phase 1-4 clinical development badge is rendered for Aluminum zirconium tetrachlorohydrex gly because the matched compound identifier rows do not contain a max-phase value.